IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 238 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $243,680 | -39.1% | 53,556 | -5.7% | 0.00% | 0.0% |
| Q2 2023 | $399,872 | +46.5% | 56,800 | +129.9% | 0.00% | 0.0% |
| Q2 2022 | $273,000 | -62.7% | 24,704 | -35.5% | 0.00% | -50.0% |
| Q4 2021 | $731,000 | +45.3% | 38,284 | +88.0% | 0.00% | 0.0% |
| Q3 2021 | $503,000 | -75.3% | 20,369 | -73.9% | 0.00% | -75.0% |
| Q2 2021 | $2,033,000 | -2.2% | 78,127 | +19.0% | 0.01% | -11.1% |
| Q1 2021 | $2,078,000 | -0.7% | 65,638 | -6.1% | 0.01% | -43.8% |
| Q1 2020 | $2,093,000 | – | 69,924 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,222,701 | $25,005,000 | 8.92% |
| Broadfin Capital, LLC | 4,894,361 | $55,062,000 | 8.10% |
| GREAT POINT PARTNERS LLC | 3,496,340 | $39,334,000 | 6.13% |
| FRAZIER MANAGEMENT LLC | 2,188,331 | $24,619,000 | 4.51% |
| Prosight Management, LP | 715,317 | $8,047,000 | 4.49% |
| Avoro Capital Advisors LLC | 8,662,720 | $97,456,000 | 4.48% |
| QVT Financial LP | 821,361 | $8,748,000 | 2.26% |
| Perceptive Advisors | 7,290,199 | $82,014,000 | 2.19% |
| Rhenman & Partners Asset Management AB | 1,290,495 | $14,518,000 | 1.46% |
| EMORY UNIVERSITY | 185,915 | $2,092,000 | 1.37% |